Bacterial Toxins, Contract Manufacturing
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
10
NCT05751837
Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal
Phase: Phase 1
Role: Collaborator
Start: Mar 16, 2023
Completion: May 30, 2024
Loading map...